These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3257833

  • 1. Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol.
    Burlingham WJ, Stratta RJ, Mason B, Ambrust MJ, Kalayoglu M, Belzer FO, Sollinger HW.
    Transplantation; 1988 Feb; 45(2):342-5. PubMed ID: 3257833
    [Abstract] [Full Text] [Related]

  • 2. Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants.
    Reed A, Pirsch J, Armbrust MJ, Burlingham WJ, Knechtle SJ, D'Alessandro AM, Sollinger HW, Lorentzen D, Kalayoglu M, Belzer FO.
    Transplantation; 1991 Feb; 51(2):382-4. PubMed ID: 1994532
    [Abstract] [Full Text] [Related]

  • 3. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes.
    Burlingham WJ, Grailer A, Sparks-Mackety EM, Sondel PM, Sollinger HW.
    Transplantation; 1987 Jan; 43(1):41-6. PubMed ID: 2948309
    [Abstract] [Full Text] [Related]

  • 4. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
    Leivestad T, Albrechtsen D, Flatmark A, Thorsby E.
    Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
    [Abstract] [Full Text] [Related]

  • 5. Current strategy for donor-specific blood transfusions including a pre- and post transplant role for azathioprine.
    Salvatierra O.
    Transplant Proc; 1988 Dec; 20(6 Suppl 8):37-41. PubMed ID: 3201558
    [Abstract] [Full Text] [Related]

  • 6. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G, Miholic J, Laczkovics A, Wollenek G, Holzinger C, Hajek-Rosenmeier A, Wuzl G, Schreiner W, Buxbaum P, Wolner E.
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [Abstract] [Full Text] [Related]

  • 7. Improved renal allograft survival following donor-specific transfusions. III. Kinetics of mixed lymphocyte culture responses before and after transplantation.
    Burlingham WJ, Grailer A, Sondel PM, Sollinger HW.
    Transplantation; 1988 Jan; 45(1):127-32. PubMed ID: 2962347
    [Abstract] [Full Text] [Related]

  • 8. [Effect of donor-specific blood transfusion on the outcome of kidney transplantation].
    Jovicić-Pavlović S, Lezaić V, Simić S, Blagojević-Lazić R, Stolić I, Simonović R, Radivojević-Djokić D, Djukanović L.
    Srp Arh Celok Lek; 2003 Jan; 131(11-12):449-53. PubMed ID: 15114786
    [Abstract] [Full Text] [Related]

  • 9. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
    Haisa M, Sakagami K, Matsumoto T, Kawamura T, Uchida S, Fujiwara T, Shiozaki S, Inagaki M, Orita K.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
    [No Abstract] [Full Text] [Related]

  • 10. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB.
    Transplantation; 1995 Dec 27; 60(12):1395-401. PubMed ID: 8545863
    [Abstract] [Full Text] [Related]

  • 11. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response.
    Burlingham WJ, Sparks EM, Sondel PM, Glass NR, Belzer FO, Sollinger HW.
    Transplantation; 1985 Jan 27; 39(1):12-7. PubMed ID: 3155578
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant antidonor antibodies and graft rejection. Evaluation by two-color flow cytometry.
    Scornik JC, Salomon DR, Lim PB, Howard RJ, Pfaff WW.
    Transplantation; 1989 Feb 27; 47(2):287-90. PubMed ID: 2645714
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for rejection in a donor-specific transfusion plus azathioprine protocol.
    Stratta RJ, Burlingham WJ, Pirsch JD, Armbrust MJ, Grailer A, Kalayoglu M, Belzer FO, Sollinger HW.
    Transplant Proc; 1988 Dec 27; 20(6):1092-5. PubMed ID: 3201555
    [No Abstract] [Full Text] [Related]

  • 14. Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Limitations to control by Imuran.
    Colombe BW, Lou CD, Salvatierra O, Garovoy MR.
    Transplantation; 1987 Oct 27; 44(4):509-15. PubMed ID: 3313837
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience.
    Burlingham WJ, Stratta R, Mason B, Lorentzen D, Feyzi J, Sollinger HW, Belzer FO.
    Transplantation; 1989 Jan 27; 47(1):140-4. PubMed ID: 2911870
    [Abstract] [Full Text] [Related]

  • 16. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
    Burlingham WJ, Pan MH, Mason B, Ceman S, Sollinger HW.
    Transplantation; 1988 Jun 27; 45(6):1066-71. PubMed ID: 3289148
    [Abstract] [Full Text] [Related]

  • 17. Donor-specific transfusion with diminished sensitization.
    Light JA, Metz S, Oddenino K, Strong DM, Simonis T, Biggers JA, Fernandez-Bueno C.
    Transplantation; 1982 Dec 27; 34(6):352-5. PubMed ID: 6218661
    [Abstract] [Full Text] [Related]

  • 18. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy.
    Salvatierra O, Melzer J, Potter D, Garovoy M, Vincenti F, Amend WJ, Husing R, Hopper S, Feduska NJ.
    Transplantation; 1985 Dec 27; 40(6):654-9. PubMed ID: 3907038
    [Abstract] [Full Text] [Related]

  • 19. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS, Suthanthiran M, Fotino M, Riggio RR, Schechter N, Stubenbord WT, Stenzel KH, Rubin AL.
    Transplantation; 1991 Feb 27; 51(2):378-81. PubMed ID: 1825244
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of the DST and Imuran-plus-DST protocols for live donor renal transplantation.
    Glass NR, Miller DT, Sollinger HW, Belzer FO.
    Transplantation; 1983 Dec 27; 36(6):636-41. PubMed ID: 6229070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.